Rituximab for the treatment of 15 patients with recurrent type 1 autoimmune pancreatitis

(1) University Hospital of Verona,Verona,Italy

(2) University of Verona,Verona,Italy

(3) Policlinico G.B. Rossi Dipt. di Gastroenterologia,Verona,Italy

(4) Az. Ospedaliera di Verona,Verona,Italy

(5) Sofar Policlinico San Matteo,Pavia,Italy

(6) University of Verona Cattedra di Gastroenterologia,Verona,Italy

This item was part of the Pancreas II (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019